These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16433720)

  • 1. Insulin allergy in a patient with Type 2 diabetes successfully treated with continuous subcutaneous insulin infusion.
    Moyes V; Driver R; Croom A; Mirakian R; Chowdhury TA
    Diabet Med; 2006 Feb; 23(2):204-6. PubMed ID: 16433720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion.
    Fujikawa T; Imbe H; Date M; Go Y; Kitaoka H
    Diabetes Res Clin Pract; 2012 Aug; 97(2):e31-3. PubMed ID: 22609054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating insulin allergy with continuous subcutaneous insulin infusion (CSII).
    Kerr D; Richardson T
    Diabet Med; 2006 Oct; 23(10):1159; author reply 1159. PubMed ID: 16978387
    [No Abstract]   [Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy.
    Hasselmann C; Pecquet C; Bismuth E; Raverdy C; Sola-Gazagnes A; Lobut JB; Carel JC; Tubiana-Rufi N
    Diabetes Metab; 2013 Apr; 39(2):174-7. PubMed ID: 23206896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of insulin allergy successfully managed using multihexamer-forming insulin degludec combined with liraglutide.
    Fujishiro M; Izumida Y; Takemiya S; Kuwano Y; Takamoto I; Suzuki R; Yamauchi T; Ueki K; Kadowaki T
    Diabet Med; 2016 Nov; 33(11):e26-e29. PubMed ID: 26485621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe insulin allergy after percutaneous transluminal coronary angioplasty.
    Wang C; Ding ZY; Shu SQ; Liu Y; Chen YC; Ran XW; An ZM; Tian HM; Tong NW; Li XJ; Yu YR
    Clin Ther; 2009 Mar; 31(3):569-74. PubMed ID: 19393846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L; Dicembrini I; Mannucci E
    Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful management of severe diabetic ketoacidosis in a patient with type 2 diabetes with insulin allergy: a case report.
    Nguyen AD; Luong CQ; Chu HC; Nguyen VKD; Nguyen CV; Nguyen TA; Nguyen QH; Mai TD; Nguyen DV; Nguyen BQ; Tran TH; Dao PV; Nguyen DT; Nguyen NN; Do SN
    BMC Endocr Disord; 2019 Nov; 19(1):121. PubMed ID: 31711488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic allergy to human insulin and its rapid and long acting analogs: successful treatment by continuous subcutaneous insulin lispro infusion.
    Castéra V; Dutour-Meyer A; Koeppel M; Petitjean C; Darmon P
    Diabetes Metab; 2005 Sep; 31(4 Pt 1):391-400. PubMed ID: 16369203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child.
    Eapen SS; Connor EL; Gern JE
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):395-7. PubMed ID: 11101184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.
    Radermecker RP; Scheen AJ
    Diabetes Metab Res Rev; 2007 Jul; 23(5):348-55. PubMed ID: 17216593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
    Abell SK; Suen M; Pease A; Boyle JA; Soldatos G; Regan J; Wallace EM; Teede HJ
    Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical, clinical approach to the assessment and management of suspected insulin allergy.
    Jacquier J; Chik CL; Senior PA
    Diabet Med; 2013 Aug; 30(8):977-85. PubMed ID: 23601039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion.
    Nagai T; Nagai Y; Tomizawa T; Mori M
    Intern Med; 1997 Aug; 36(8):575-8. PubMed ID: 9260776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes.
    Hanaire-Broutin H; Melki V; Bessières-Lacombe S; Tauber JP
    Diabetes Care; 2000 Sep; 23(9):1232-5. PubMed ID: 10977011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Short acting insulin analogues for treating diabetic patients with CSII (continuous subcutaneous insulin infusion)].
    Jermendy G
    Orv Hetil; 2006 Nov; 147(46):2223-6. PubMed ID: 17396394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive insulin therapy combined with metformin is associated with reduction in both glucose variability and nocturnal hypoglycaemia in patients with type 2 diabetes.
    Zhang Y; Zhao Z; Wang S; Zhu W; Jiang Y; Sun S; Chen C; Wang K; Mu L; Cao J; Zhou Y; Gu W; Hong J; Wang W; Ning G
    Diabetes Metab Res Rev; 2017 Oct; 33(7):. PubMed ID: 28609547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I allergy to insulin: case report and review of localized and systemic reactions to insulin.
    Hoffman AG; Schram SE; Ercan-Fang NG; Warshaw EM
    Dermatitis; 2008; 19(1):52-8. PubMed ID: 18346398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes.
    Colquitt JL; Green C; Sidhu MK; Hartwell D; Waugh N
    Health Technol Assess; 2004 Oct; 8(43):iii, 1-171. PubMed ID: 15488165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.